Clinical trials
catalyst calendar across sponsors →Studies where STAA is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
5 interventional · 4 with posted results
Held by 12 tracked-famous managers (Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, Squarepoint Ops LLC, TWO SIGMA INVESTMENTS, LP, +7 more) · FINRA short interest 4.3 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| STAAR Visian Toric ICL Post-Approval StudyNCT04516772results2026-03-13Change in Axis Orientation of the TICLOpen-label · TreatmentStudy Protocol and Statistical Analysis Plan ↗ | Not applicable | Completed | Device: Visian TICL | Myopic Astigmatism | 125 | 2024-12-11actual | 2026-03-13 |
| A Clinical Evaluation of a Phakic Intraocular LensNCT07291739Change in visual acuityOpen-label · Treatment | Not applicable | Completed | Device: Implantable Collamer Lens (ICL) | Myopia, Hyperopia, Astigmatism, Presbyopia | 47 | 2024-10-18actual | 2025-12-18 |
| Post-Market Evaluation of the EVO ICLNCT05538754results2024-12-03Elevated Intraocular Pressure (IOP) in Primary Eyes ≥ 30 mmHgOpen-label · TreatmentStudy Protocol and Statistical Analysis Plan ↗ | Not applicable | Completed | Device: EVO ICL | Myopia, Myopic Astigmatism | 205 | 2023-09-21actual | 2026-03-05 |
| Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)NCT04283149results2022-07-27Number of Primary Eyes Requiring Peripheral Iridotomy (PI)Non-randomized · Open-label · TreatmentStudy Protocol and Statistical Analysis Plan ↗ | Not applicable | Completed | Device: EVO/EVO+ Visian ICL | Myopia, Myopic Astigmatism | 327 | 2021-04-05actual | 2026-03-16 |
| Clinical Performance of a Phakic Intraocular Lens (IOL)NCT03499821results2022-09-21Number of Eyes With Monocular Uncorrected Near Visual Acuity of 20/40 or Better at 40 cm 6 Months After ImplantationOpen-label · TreatmentStudy Protocol and Statistical Analysis Plan ↗ | Not applicable | Completed | Device: EDOF ICL | Presbyopia | 41 | 2019-07-09actual | 2026-03-16 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19